SCHEMBL7975372

SCHEMBL7975372

Cc1cccc(Cn2cnc(N)c2C(N)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP11B1 P15538 2/20 0.51
▸ CYP11B2 P19099 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ ADRA1D P25100 1/20 0.49
▸ CYP1A2 P05177 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ TSHR P16473 4/20 0.44
▸ HPGD P15428 4/20 0.44
▸ HTT P42858 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989347 0.86 CYP11B1 (0.44) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7974168 0.84 CDK9 (0.45) ALDH1A1CYP11B1CYP11B2TSHRSMN1; SMN2
SCHEMBL7974026 0.84 KDM4E (0.58) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7988093 0.84 FYN (0.43) TSHRGAAPKMKMT2A
SCHEMBL7984239 0.84 ADRA1D (0.52) LMNAADRA1DADORA2AADORA1TP53
SCHEMBL7988530 0.83 SMN1; SMN2 (0.46) ALDH1A1CYP11B1CYP11B2LMNACYP1A2
SCHEMBL5483136 0.83 PKM (0.59) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
Hydrochloric Acid SCHEMBL7987445 0.82 PKM (0.57) ALDH1A1CYP11B1CYP11B2LMNAADRA1D
SCHEMBL7974034 0.81 ATM (0.48) ALDH1A1LMNASMN1; SMN2TP53MAPT
SCHEMBL7987961 0.80 MAPT (0.47) ALDH1A1CYP11B1CYP11B2LMNAADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback